AGENDA SUBJECT TO CHANGE AND WILL BE REGULARLY UPDATED.
AT THE END OF EACH DAY THE VIDEO ARCHIVE OF ALL SESSIONS WILL BE UP AND AVAILABLE FOR REVIEW BY ALL ATTENDEES.
AGENDA: DAY I
MONDAY, JUNE 22, 2020
(All times below are Eastern Daylight Time)
OPENING PLENARY SESSION
12:45 pm EDT
Chair’s Welcome and Introductions; Attendee Polling
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer is the Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University. She focuses on health system transformation, biopharmaceutical policy, and other key health policy issues. Dentzer is one of the nation’s most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare. She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care. Previously, Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, she was senior policy adviser to the Robert Wood Johnson Foundation, and before that, was the editor-in-chief of the policy journal Health Affairs. She was the on-air Health Correspondent for the PBS NewsHour. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation. Dentzer is an elected member of the National Academy of Medicine (formerly the Institute of Medicine) and serves on the Board on Population Health and Public Health Practice of the National Academies of Science, Medicine, and Engineering. She is an elected member of the Council on Foreign Relations; a fellow of the National Academy of Social Insurance; and a fellow of the Hastings Center, a nonpartisan bioethics research institute. She is also a member of the Board of Directors of the International Rescue Committee, a member of the board of directors of Research!America, which advocates on behalf of biomedical and health-related research; and a member of the board of directors of the Public Health Institute, a nonprofit organization addressing public health issues and solutions nationwide. Dentzer serves on the global access public policy advisory committee for Roche, the international biopharmaceutical company based in Basel, Switzerland. She is a member of the Boards of Advisors for RAND Health and for the Philip R. Lee Institute of Health Policy Studies at the University of California-San Francisco. From 2011 to 2017 she was public member of the Board of Directors of the American Board of Medical Specialties, which assists 24 medical specialty boards in the ongoing evaluation and certification of physicians. Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. She serves on the advisory board for the Center for Global Health Equity at Dartmouth, and previous was a member of the Board of Advisors of Dartmouth’s Geisel School of Medicine or more than two decades.
1:00 pm EDT
How the Pandemic Has Hit the Nation’s Health System
Ashish Jha, MD, MPH
KT Li Professor of Global Health and Director, Harvard Global Health Institute, Department of Health Policy and Management, TH Chan School of Public Health, Cambridge, MA
KT Li Professor of Global Health and Director, Harvard Global Health Institute, Department of Health Policy and Management, TH Chan School of Public Health, Cambridge, MA
Dr. Jha is the K.T. Li Professor of Global Health at the Harvard TH Chan School of Public Health and Director of the Harvard Global Health Institute (HGHI). He is a practicing General Internist and is also Professor of Medicine at Harvard Medical School. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine. In September, Dr. Jha will begin work as the Dean of the Brown University School of Public Health. Dr. Jha’s research focuses on improving the quality and costs of healthcare systems with a specialized focus on the impact of policies. He has led groundbreaking research around Ebola and is now on the frontlines of the COVID-19 response. HGHI is providing critical analysis and data on national and state by state testing with Dr. Jha, a vocal advocate for increased testing and contact tracing who has written extensively on the subject.
Michael T. Osterholm, PhD, MPH
Regents Professor, McKnight Presidential Endowed Chair in Public Health, Director, Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Author, Deadliest Enemy: Our War Against Killer Germs, Former Special Advisor, Bioterrorism & Public Health, HHS Secretary, Minneapolis, MN
Regents Professor, McKnight Presidential Endowed Chair in Public Health, Director, Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Author, Deadliest Enemy: Our War Against Killer Germs, Former Special Advisor, Bioterrorism & Public Health, HHS Secretary, Minneapolis, MN
Dr. Osterholm is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, a professor in the Technological Leadership Institute, College of Science and Engineering, and an adjunct professor in the Medical School, all at the University of Minnesota. He previously served as a Science Envoy for Health Security on behalf of the US Department of State. He is also on the Board of Regents at Luther College in Decorah, Iowa, is a member of the National Academy of Medicine (NAM) and the Council of Foreign Relations.
Dr. Osterholm has been appointed to numerous boards, forums, councils, and as special advisor on issues related to bioterrorism and public health preparedness.
Previously, Dr. Osterholm served for 24 years in various roles at the Minnesota Department of Health (MDH), the last 15 as state epidemiologist and chief of the Acute Disease Epidemiology Section. He is past president of the Council of State and Territorial Epidemiologists (CSTE) and has served on the CDC’s National Center for Infectious Diseases Board of Scientific Counselors. He is a frequent consultant to the World Health Organization (WHO), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Department of Defense, and the CDC. He is a fellow of the American College of Epidemiology and the Infectious Diseases Society of America (IDSA).
Dr. Osterholm has been appointed to numerous boards, forums, councils, and as special advisor on issues related to bioterrorism and public health preparedness.
Previously, Dr. Osterholm served for 24 years in various roles at the Minnesota Department of Health (MDH), the last 15 as state epidemiologist and chief of the Acute Disease Epidemiology Section. He is past president of the Council of State and Territorial Epidemiologists (CSTE) and has served on the CDC’s National Center for Infectious Diseases Board of Scientific Counselors. He is a frequent consultant to the World Health Organization (WHO), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Department of Defense, and the CDC. He is a fellow of the American College of Epidemiology and the Infectious Diseases Society of America (IDSA).
Interviewed by:
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer is the Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University. She focuses on health system transformation, biopharmaceutical policy, and other key health policy issues. Dentzer is one of the nation’s most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare. She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care. Previously, Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, she was senior policy adviser to the Robert Wood Johnson Foundation, and before that, was the editor-in-chief of the policy journal Health Affairs. She was the on-air Health Correspondent for the PBS NewsHour. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation. Dentzer is an elected member of the National Academy of Medicine (formerly the Institute of Medicine) and serves on the Board on Population Health and Public Health Practice of the National Academies of Science, Medicine, and Engineering. She is an elected member of the Council on Foreign Relations; a fellow of the National Academy of Social Insurance; and a fellow of the Hastings Center, a nonpartisan bioethics research institute. She is also a member of the Board of Directors of the International Rescue Committee, a member of the board of directors of Research!America, which advocates on behalf of biomedical and health-related research; and a member of the board of directors of the Public Health Institute, a nonprofit organization addressing public health issues and solutions nationwide. Dentzer serves on the global access public policy advisory committee for Roche, the international biopharmaceutical company based in Basel, Switzerland. She is a member of the Boards of Advisors for RAND Health and for the Philip R. Lee Institute of Health Policy Studies at the University of California-San Francisco. From 2011 to 2017 she was public member of the Board of Directors of the American Board of Medical Specialties, which assists 24 medical specialty boards in the ongoing evaluation and certification of physicians. Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. She serves on the advisory board for the Center for Global Health Equity at Dartmouth, and previous was a member of the Board of Advisors of Dartmouth’s Geisel School of Medicine or more than two decades.
1:30 pm EDT
Pandemic Preparedness and Response
Nicole Lurie, MD, MSPH
Strategic Advisor to the CEO, CEPI and Harvard Medical School, Washington, DC
Strategic Advisor to the CEO, CEPI and Harvard Medical School, Washington, DC
Dr. Lurie served as the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS) during the Obama Administration. She is currently a consultant to the World Bank and the Coalition for Epidemic Preparedness Initiatives. In her role at HHS, Dr. Lurie provided leadership in preventing, responding to and recovering from the adverse health effects of public health emergencies and disasters. She had spent previous portions of her career at the University of Minnesota and at RAND, where her focus was on access to and quality of care, health equity, and population health. She has led multiple, successful community-wide initiatives to improve the health of underserved populations. Dr. Lurie has Penn roots, having attended college and medical school here. She was the founding graduate fellow of Ware College House. She went on to complete her residency and Master of Science in Public Health as a Robert Wood Johnson Foundation Clinical Scholar at the University of California, Los Angeles. During her time at HHS, she served as a mentor to several Penn Clinical Scholars. Dr. Lurie is the recipient of numerous awards, including the Association for Health Services Research Young Investigator Award, the Nellie Westerman Prize for Research in Ethics, the Heroine in Health Care Award, the University of Pennsylvania School of Medicine’s Distinguished Alumni Award, and she is a member of the Institute of Medicine. She continues to practice clinical medicine in the health care safety net in Washington, DC.
1:45 pm EDT
Keynote Address: Payment Reforms in Health System Recovery and Resilience
Mark McClellan, MD, PhD
Director, Robert J Margolis Center for Health Policy and Margolis Professor of Business, Medicine and Health Policy, Duke University, Former CMS Administrator and FDA Commissioner, Washington, DC
Director, Robert J Margolis Center for Health Policy and Margolis Professor of Business, Medicine and Health Policy, Duke University, Former CMS Administrator and FDA Commissioner, Washington, DC
Mark McClellan is Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Health Care and Seer, and is co-chair of the Guiding Committee for the Health Care Payment Learning and Action Network.
2:10 pm EDT
Hospital & Health System Perspectives
Michael J. Dowling
Chief Executive Officer, Northwell Health, Former Senior Vice President, Empire Blue Cross and Blue Shield, New York, NY
Chief Executive Officer, Northwell Health, Former Senior Vice President, Empire Blue Cross and Blue Shield, New York, NY
Michael Dowling is one of health care’s most influential voices, taking a stand on societal issues such as gun violence and immigration that many health system CEOs shy away from. As president and CEO of Northwell Health, he leads a clinical, academic and research enterprise with a workforce of more than 72,000 and annual revenue of $13.5 billion. Northwell is the largest health care provider and private employer in New York State, caring for more than two million people annually through a vast network of nearly 800 outpatient facilities, including 220 primary care practices, 52 urgent care centers, home care, rehabilitation and end-of-life programs, and 23 hospitals. Mr. Dowling served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services. Before his public service career, Mr. Dowling was a professor of social policy and assistant dean at the Fordham University Graduate School of Social Services, and director of the Fordham campus in Westchester County.
Carol A. Gomes, MPH
Chief Executive Officer and Chief Operating Officer and Former Chief Quality Officer, Stony Brook University Hospital, Stony Brook, NY
Chief Executive Officer and Chief Operating Officer and Former Chief Quality Officer, Stony Brook University Hospital, Stony Brook, NY
Carol Gomes is a member of the senior executive team, serving as the Chief Executive Officer and Chief Operating Officer at Stony Brook University Hospital. Formerly, she was the Chief Quality Officer and Associate Director for Quality Management with administrative oversight for the departments of Continuous Quality Improvement, Decision Support Services, Clinical Pathways and Management Engineering. She was also the Associate Director for Neurosciences. She has served on the Malcolm Baldrige Quality Program’s Board of Examiners for nearly ten years, most recently as a Senior Examiner and Alumni Examiner. She teaches for the School of Health Technology and Management. She has served on the Stony Brook University Alumni Association Board and currently serves as the Vice Chair of the Vizient Senior Operations Officer Network Steering Committee. and serves as a board member on numerous boards associated with healthcare activities, including the Health Care Leaders of New York through the American College of Healthcare Executives.
Wright L. Lassiter III, MHA
President and Chief Executive Officer, Henry Ford Health System, Former CEO, Alameda Health System, Detroit, MI
President and Chief Executive Officer, Henry Ford Health System, Former CEO, Alameda Health System, Detroit, MI
Wright Lassiter is President and CEO of Henry Ford Health System, a $7.5 billion health system comprised of six hospitals, a health plan and a wide range of ambulatory and retail and related health services consisting of more than 250 locations and 32,000 employees. He has amassed significant experience in governance, strategic planning, market expansion, health care M&A, performance improvement, and corporate turnaround.
Lassiter joined Henry Ford in December 2014 and assumed the role of President & CEO in 2016. Since his arrival, he led the Board through a comprehensive strategic planning effort to reposition Henry Ford for the future.
Lassiter has nearly 30 years of experience working in large, complex academic health systems in the most competitive markets across the United States, including Dallas Methodist Health System and JPS Health Network in Fort Worth, Texas. Prior to joining Henry Ford, Lassiter was CEO of Alameda Health System in Oakland, California. He is a seasoned health care executive, with significant board experience across multiple corporate and non-profit sectors.
Lassiter joined Henry Ford in December 2014 and assumed the role of President & CEO in 2016. Since his arrival, he led the Board through a comprehensive strategic planning effort to reposition Henry Ford for the future.
Lassiter has nearly 30 years of experience working in large, complex academic health systems in the most competitive markets across the United States, including Dallas Methodist Health System and JPS Health Network in Fort Worth, Texas. Prior to joining Henry Ford, Lassiter was CEO of Alameda Health System in Oakland, California. He is a seasoned health care executive, with significant board experience across multiple corporate and non-profit sectors.
Thomas M. Priselac
President and Chief Executive Officer and Warschaw Law Chair in Health Care Leadership, Cedars-Sinai Health System, Adjunct Professor, UCLA Fielding School of Public Health, Los Angeles, CA
President and Chief Executive Officer and Warschaw Law Chair in Health Care Leadership, Cedars-Sinai Health System, Adjunct Professor, UCLA Fielding School of Public Health, Los Angeles, CA
Mr. Priselac has been associated with Cedars-Sinai since 1979, has served as President and CEO of Cedars-Sinai since 1994 and was also named President and CEO of the Cedars-Sinai Health System when it was formed in 2017.
Throughout his career, Mr. Priselac has been a leader in the development of strategic and operational innovations to foster high quality, safe and efficient healthcare as well as being actively involved in healthcare delivery and finance policy. He is a past Chair of the American Hospital Association Board of Trustees and a past Chair of the Association of American Medical Colleges.
An author and invited speaker on a variety of contemporary issues facing the healthcare field, he is the holder of the Warschaw/Law endowed Chair in Healthcare Leadership at Cedars-Sinai Medical Center.
Throughout his career, Mr. Priselac has been a leader in the development of strategic and operational innovations to foster high quality, safe and efficient healthcare as well as being actively involved in healthcare delivery and finance policy. He is a past Chair of the American Hospital Association Board of Trustees and a past Chair of the Association of American Medical Colleges.
An author and invited speaker on a variety of contemporary issues facing the healthcare field, he is the holder of the Warschaw/Law endowed Chair in Healthcare Leadership at Cedars-Sinai Medical Center.
Interviewed by:
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer is the Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University. She focuses on health system transformation, biopharmaceutical policy, and other key health policy issues. Dentzer is one of the nation’s most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare. She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care. Previously, Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, she was senior policy adviser to the Robert Wood Johnson Foundation, and before that, was the editor-in-chief of the policy journal Health Affairs. She was the on-air Health Correspondent for the PBS NewsHour. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation. Dentzer is an elected member of the National Academy of Medicine (formerly the Institute of Medicine) and serves on the Board on Population Health and Public Health Practice of the National Academies of Science, Medicine, and Engineering. She is an elected member of the Council on Foreign Relations; a fellow of the National Academy of Social Insurance; and a fellow of the Hastings Center, a nonpartisan bioethics research institute. She is also a member of the Board of Directors of the International Rescue Committee, a member of the board of directors of Research!America, which advocates on behalf of biomedical and health-related research; and a member of the board of directors of the Public Health Institute, a nonprofit organization addressing public health issues and solutions nationwide. Dentzer serves on the global access public policy advisory committee for Roche, the international biopharmaceutical company based in Basel, Switzerland. She is a member of the Boards of Advisors for RAND Health and for the Philip R. Lee Institute of Health Policy Studies at the University of California-San Francisco. From 2011 to 2017 she was public member of the Board of Directors of the American Board of Medical Specialties, which assists 24 medical specialty boards in the ongoing evaluation and certification of physicians. Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. She serves on the advisory board for the Center for Global Health Equity at Dartmouth, and previous was a member of the Board of Advisors of Dartmouth’s Geisel School of Medicine or more than two decades.
3:05 pm EDT
Federal Support for Hospitals and Health Systems Recovering from the COVID-19 Pandemic
Charles n. “Chip” Kahn
President and Chief Executive Officer, Federation of American Hospitals, Former President, Health Insurance Association of America, Former Staff Director, Health Subcommittee, Ways and Means Committee, US House of Representatives, Washington, DC
President and Chief Executive Officer, Federation of American Hospitals, Former President, Health Insurance Association of America, Former Staff Director, Health Subcommittee, Ways and Means Committee, US House of Representatives, Washington, DC
Since June 2001, Chip has served as President and CEO of the Federation of American Hospitals, the national advocacy organization for investor-owned hospitals. In 2016, he was appointed the co-chair of the Measure Applications Partnership (MAP) Coordinating Committee of the National Quality Forum (NQF). He also is a former member of the NQF’s Governing Board.
He was recently chosen to serve on the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Quality for People with Serious Illness.
Mr. Kahn is a member of the Board of Directors of AdhereHealth and serves on the U.S. Executive Council for the Center for Digital Innovation (CDI).
Previously, Mr. Kahn served as a principal of the former Hospital Quality Alliance (HQA) and as a Commissioner of the American Health Information Community. Before coming to the FAH, Mr. Kahn was one of the nation’s top public policy leaders for the health insurance industry.
Mr. Kahn has a long and distinguished career as a professional staff person on Capitol Hill, specializing in health policy issues.
He was recently chosen to serve on the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Quality for People with Serious Illness.
Mr. Kahn is a member of the Board of Directors of AdhereHealth and serves on the U.S. Executive Council for the Center for Digital Innovation (CDI).
Previously, Mr. Kahn served as a principal of the former Hospital Quality Alliance (HQA) and as a Commissioner of the American Health Information Community. Before coming to the FAH, Mr. Kahn was one of the nation’s top public policy leaders for the health insurance industry.
Mr. Kahn has a long and distinguished career as a professional staff person on Capitol Hill, specializing in health policy issues.
Richard J. Pollack
President and Chief Executive Officer, American Hospital Association, Former Legislative Assistant to Congressman David Obey (D/WI), US House of Representatives, Washington, DC
President and Chief Executive Officer, American Hospital Association, Former Legislative Assistant to Congressman David Obey (D/WI), US House of Representatives, Washington, DC
Rick Pollack is president and CEO of the American Hospital Association (AHA). Rick leads the association in representing hospitals and health systems in shaping the health care landscape, representing the nation’s hospitals on advocacy issues, and developing strategies and tools to help members provide better care to the patients and communities they serve. He serves on the AHA Board of Trustees, and the Board of Directors of the Coalition to Protect America’s Health Care. In addition, he is a member of the U.S. Chamber of Commerce Committee of 100, and the Special Medical Advisory Group to the Secretary of the U. S. Department of Veteran’s Affairs. Previously, Rick was a legislative assistant to Rep. David Obey of Wisconsin, a legislative representative for the American Nurses Association, and served as AHA’s vice president for legislation, and executive vice president for advocacy and public policy.
Bruce Siegel, MD, MPH
President and Chief Executive Officer, America’s Essential Hospitals, Former CEO, New York City Health and Hospitals Corporation (HHC) and Tampa General Healthcare, Washington, DC
President and Chief Executive Officer, America’s Essential Hospitals, Former CEO, New York City Health and Hospitals Corporation (HHC) and Tampa General Healthcare, Washington, DC
Bruce Siegel is President and CEO with America’s Essential Hospitals. With an extensive background in health care management, policy, and public health, Siegel has the blend of experience necessary to lead America’s Essential Hospitals and its members through the changing health care landscape and into a sustainable future. Since joining America’s Essential Hospitals in 2010, Siegel has guided the association toward realizing its strategic vision of helping members transform into integrated delivery systems and leaders in access and quality. His intimate knowledge of member needs comes in part from his direct experience as president and CEO of two member systems: New York City Health and Hospitals Corporation and Tampa General Healthcare.
Just before joining America’s Essential Hospitals, Siegel served as director of the Center for Health Care Quality and professor of health policy at The George Washington University School of Public Health and Health Services. He also served as New Jersey’s commissioner of health. Among his many accomplishments, Siegel led groundbreaking work on quality and equity with funding from the Robert Wood Johnson Foundation. He is past-chair of the National Quality Forum board and the National Advisory Council for Healthcare Research and Quality.
Just before joining America’s Essential Hospitals, Siegel served as director of the Center for Health Care Quality and professor of health policy at The George Washington University School of Public Health and Health Services. He also served as New Jersey’s commissioner of health. Among his many accomplishments, Siegel led groundbreaking work on quality and equity with funding from the Robert Wood Johnson Foundation. He is past-chair of the National Quality Forum board and the National Advisory Council for Healthcare Research and Quality.
Interviewed by:
Joseph Fifer
President and Chief Executive Officer, Health Care Financial Management Association (HFMA), Former Vice President, Hospital Finance, Spectrum Health, Chicago, IL
Joseph Fifer
President and Chief Executive Officer, Health Care Financial Management Association (HFMA), Former Vice President, Hospital Finance, Spectrum Health, Chicago, IL
Mr. Fifer is President and CEO of HFMA. Prior to assuming this position in 2012, Joe spent 11 years as vice president of hospital finance at Spectrum Health in Grand Rapids, Mich. He also spent time with McLaren Health Care Corporation, Flint, Mich., as vice president of finance and with Ingham Regional Medical Center, Lansing, Mich., as senior vice president of finance and CFO. Joe started his career with nine years at Ernst & Young, also in Michigan. An HFMA member since 1983, he served as Chair of the Board of Directors, two terms as a board member, and as a chapter president. He has received HFMA’s Medal of Honor, and the Follmer Bronze, Reeves Silver, and Muncie Gold merit awards.
3:30 pm EDT
Interview of Michael W. Cropp, MD, MBA, President and CEO, Independent Health & Ceci Connolly, President & CEO, Alliance of Community Health Plans (ACHP)
Ceci Connolly
President and Chief Executive Officer, Alliance of Community Health Plans (ACHP), Founding Member, Women of Impact, Co-author of Landmark: America’s New Health-Care Law and What It Means for Us All, Washington, DC
President and Chief Executive Officer, Alliance of Community Health Plans (ACHP), Founding Member, Women of Impact, Co-author of Landmark: America’s New Health-Care Law and What It Means for Us All, Washington, DC
Ceci Connolly is President and CEO of the Alliance of Community Health Plans (ACHP), the trade association for nonprofit, community health plans. A prominent voice in health care for more than a decade, Connolly has served as a national correspondent for the Washington Post and a leader at international consulting firms, including PwC and McKinsey. She is coauthor of LANDMARK: The Inside Story of America’s Health Law and What it Means for Us All and has been published in numerous publications, including the New England Journal of Medicine. Connolly was included on Business Insider’s inaugural list of “DC Health Care Power Players” and was also the first non-physician to receive the prestigious Mayo Clinic Plummer Society award for promoting deeper understanding of science and medicine.
Michael W. Cropp, MD, MBA
President and Chief Executive Officer, Independent Health, Chairman, Alliance of Community Health Plans (ACHP), Buffalo, NY
President and Chief Executive Officer, Independent Health, Chairman, Alliance of Community Health Plans (ACHP), Buffalo, NY
Dr. Cropp is the president and chief executive officer of Independent Health. Under his leadership, the organization delivers products and services that improve the health of almost 375,000 customers – and has been consistently recognized nationally for excellence in quality, service and innovation. His focus on building leadership capacity for sustainable accountable quality care reaches beyond Western New York as he serves in leadership roles on the boards of national health care organizations, including America’s Health Insurance Plans (AHIP). Dr. Cropp is chairman of the Alliance of Community Health Plans (ACHP). In addition, he has established several community initiatives to improve access, quality and affordability of health care. He is the founding chairman of the P2 Collaborative of Western New York – one of the original grantees in the Robert Wood Johnson Foundation Aligning Forces for Quality (AF4Q) grant. He is also the founding chairman of the Western New York Clinical Information Exchange (HEALTHeLINK), a consortium of multiple community stakeholders working to provide electronic access to health information across our entire community – a recipient of the government’s Beacon Community award.
Interviewed by:
Merrill Goozner
Former Editor, Modern Healthcare, Former Chief Economics Correspondent, Chicago Tribune, Author, The $800 Million Pill: The Truth Behind the Cost of New Drugs, Chicago, IL
Merrill Goozner
Former Editor, Modern Healthcare, Former Chief Economics Correspondent, Chicago Tribune, Author, The $800 Million Pill: The Truth Behind the Cost of New Drugs, Chicago, IL
Since retiring from day-to-day management at Modern Healthcare in May 2017, Merrill Goozner continues to write a weekly opinion column for the nation’s leading healthcare trade journal. He also speaks and serves as moderator for panel discussions at numerous industry and Modern Healthcare events. From 2012 to 2017, Goozner was responsible for the editorial direction and content for Modern Healthcare’s magazine, e-newsletters, and website. Prior to joining Modern Healthcare, his journalism career spanned nearly 40 years as an editor, writer and journalism educator. In 2004, he authored The $800 Million Pill: The Truth Behind the Cost of New Drugs (University of California Press). He previously served as a foreign, national, and chief economics correspondent for the Chicago Tribune and a professor of journalism at New York University. He has contributed numerous articles to both the lay press and scientific publications over the course of his career.
3:50 pm EDT
Interview of Bruce D. Broussard, MBA, President and CEO, Humana
Bruce D. Broussard, MBA
President and Chief Executive Officer, Humana, Former Chair and Chief Executive Officer, US Oncology, Louisville, KY
President and Chief Executive Officer, Humana, Former Chair and Chief Executive Officer, US Oncology, Louisville, KY
Bruce Broussard, President and CEO, joined Humana in 2011. Under his leadership, Humana has created an integrated care delivery model centered on improving health outcomes, driving lower costs, enhancing quality, and providing a simple and personalized member experience.
Bruce brings to Humana a wide range of executive leadership experience.
Prior to joining Humana, Bruce was Chief Executive Officer of McKesson Specialty/US Oncology, Inc. At US Oncology, Bruce served in a number of senior executive roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board.
Bruce plays a leadership role in key business advocacy organizations such as The Business Council, the American Heart Association CEO Roundtable, the Business Roundtable and America’s Health Insurance Plans (AHIP). He is also a member of the Board of Directors of KeyCorp and the World Economic Forum Health Governors Board.
Bruce brings to Humana a wide range of executive leadership experience.
Prior to joining Humana, Bruce was Chief Executive Officer of McKesson Specialty/US Oncology, Inc. At US Oncology, Bruce served in a number of senior executive roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board.
Bruce plays a leadership role in key business advocacy organizations such as The Business Council, the American Heart Association CEO Roundtable, the Business Roundtable and America’s Health Insurance Plans (AHIP). He is also a member of the Board of Directors of KeyCorp and the World Economic Forum Health Governors Board.
Interviewed by:
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer
Senior Policy Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC (Summit Chair)
Susan Dentzer is the Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University. She focuses on health system transformation, biopharmaceutical policy, and other key health policy issues. Dentzer is one of the nation’s most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare. She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care. Previously, Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, she was senior policy adviser to the Robert Wood Johnson Foundation, and before that, was the editor-in-chief of the policy journal Health Affairs. She was the on-air Health Correspondent for the PBS NewsHour. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation. Dentzer is an elected member of the National Academy of Medicine (formerly the Institute of Medicine) and serves on the Board on Population Health and Public Health Practice of the National Academies of Science, Medicine, and Engineering. She is an elected member of the Council on Foreign Relations; a fellow of the National Academy of Social Insurance; and a fellow of the Hastings Center, a nonpartisan bioethics research institute. She is also a member of the Board of Directors of the International Rescue Committee, a member of the board of directors of Research!America, which advocates on behalf of biomedical and health-related research; and a member of the board of directors of the Public Health Institute, a nonprofit organization addressing public health issues and solutions nationwide. Dentzer serves on the global access public policy advisory committee for Roche, the international biopharmaceutical company based in Basel, Switzerland. She is a member of the Boards of Advisors for RAND Health and for the Philip R. Lee Institute of Health Policy Studies at the University of California-San Francisco. From 2011 to 2017 she was public member of the Board of Directors of the American Board of Medical Specialties, which assists 24 medical specialty boards in the ongoing evaluation and certification of physicians. Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. She serves on the advisory board for the Center for Global Health Equity at Dartmouth, and previous was a member of the Board of Advisors of Dartmouth’s Geisel School of Medicine or more than two decades.